Pharmaceutical Grade Ursodeoxycholic Acid CAS No.: 128-13-2 with High Quality GMP Factory USP Ep Jp IP

Product Details
Customization: Available
Certification: RoHS, BRC, ISO, FDA, HACCP, GMP
Storage Method: Normal
Still deciding? Get samples of US$ 200/Piece
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Number of Employees
10
Year of Establishment
2017-08-09
  • Pharmaceutical Grade Ursodeoxycholic Acid CAS No.: 128-13-2 with High Quality GMP Factory USP Ep Jp IP
  • Pharmaceutical Grade Ursodeoxycholic Acid CAS No.: 128-13-2 with High Quality GMP Factory USP Ep Jp IP
  • Pharmaceutical Grade Ursodeoxycholic Acid CAS No.: 128-13-2 with High Quality GMP Factory USP Ep Jp IP
  • Pharmaceutical Grade Ursodeoxycholic Acid CAS No.: 128-13-2 with High Quality GMP Factory USP Ep Jp IP
  • Pharmaceutical Grade Ursodeoxycholic Acid CAS No.: 128-13-2 with High Quality GMP Factory USP Ep Jp IP
  • Pharmaceutical Grade Ursodeoxycholic Acid CAS No.: 128-13-2 with High Quality GMP Factory USP Ep Jp IP
Find Similar Products

Basic Info.

Model NO.
HSUDCA001
Extraction Process
Chemical
Application
Cosmetics, Food, Health Care Products, Medicine, Intermediate of Udca
State
Powder
Extract Source
Cow
Name
Ursodeoxycholic Acid
Name-2
Ursodiol
Synonyms
3, 7-Dihydroxycholan-24-Oic Acid
Synonyms-2
3alpha, 7beta-Dihydroxy-6beta-Cholan-24-Oic Acid
Molecular Formula
C24h40o4
Molecular Weight
392.58
CAS Registry Number
128-13-2
Melting Point
203-206 ºC
Standard-1
Ep9
Standard-2
USP43
Standard-3
IP
Grade Standard
Pharmaceutical Grade
Appearance
White Crystalline Powder
Purity
98%
Using
Intermediate for Udca
Transport Package
25kgs/Drum
Specification
EP9; USP; IP
Trademark
HAOSAIL
Origin
Qingdao China
HS Code
2918990090
Production Capacity
200 Mt Per Year

Product Description

We are the most professional real "MANUFACTURER" and "SUPPLIER" of CHOLIC ACID series materials on MIC, welcome the enquiry from both Foreign and Domestic customers.

 

We can provide:

(1) Cholic Acid (Free Grade 50%)                                                             CAS #:81-25-94

(2) Cholic Acid (Food Grade 90%)                                                            CAS #:81-25-94

(3) Cholic Acid (Pharmaceutical Grade 95%;98%)                                CAS #:81-25-94

(4) Chenodeoxycholic Acid(intermediate of Ursodeoxycholic Acid)      CAS #:474-25-9

(5) 3alpha-Hydroxy-7-oxo-5beta-cholic acid(7K-LCA)                           CAS #:4651-67-6

(6) Ursodeoxycholic Acid(EP9/USP/IP GRADE WITH GMP)               CAS #:128-13-2  

(7)Tauroursodeoxycholic acid   EP9                                                           CAS #:14605-22-2
(8)Obeticholic Acid  (OBCA)  98%/99%                                                   CAS #:459789-99-2
(9)Obeticholic Acid Intermediate-1(OB N-1)                                            CAS #:915038-26-5
(10)Obeticholic Acid Intermediate-2(OB N-2)                                          CAS #:1516887-33-4
(11)Obeticholic Acid Intermediate-3(OB M-2)                                          CAS#:1352328-66-5

 

Description:

Product Name:Ursodeoxycholic acid

CAS:128-13-2
Molecular Formula: C24H400
4
Molecular Mass:392.58
[Appearance]: white crystal powder, no foreign substance, no obvious odor
[Melting Point]:203~2062.0ºC
[Loss on Dry]: ≤1.0%
[Residue on Ignition]: ≤0.1%
[Heavy Metal ]: ≤10ppm
[Assay Determination]: 98.0%~101.0% (dries basis)
[Related Substance]:the single impurity≤0.1%, total impurities≤2.0%
[Package and Storage Condition]: 25kg/drum, store and seal away from light

 

What is URSODEOXYCHOLIC ACID?
Ursodeoxycholic acid (UDCA), also known as ursodiol, is a secondary bile acid, produced in humans and most other species from metabolism by intestinal bacteria. It is synthesized in the liver in some species, and was first identified in bear bile, which is the derivation of its name Ursus.

Medical uses:
UDCA has been used as medical therapy in gallstone disease (cholelithiasis) and for biliary sludge. UDCA helps reduce the cholesterol saturation of bile and leads to gradual dissolution of cholesterol-rich gallstones.
UDCA may be given after bariatric surgery to prevent cholelithiasis, which commonly occurs due to the rapid weight loss producing biliary cholesterol oversaturation and also biliary dyskinesia secondary hormonal changes.

Primary biliary cholangitis
UDCA is used as therapy in primary biliary cholangitis (PBC; previously known as primary biliary cirrhosis) where it can produce an improvement in biomarkers. Meta-analyses have borne out conflicting results on the mortality benefit.However analyses that exclude trials of short duration (i.e. < 2 years) have demonstrated a survival benefit and are generally considered more clinically relevant. A Cochrane systematic review in 2012 found no significant benefit in reducing mortality, the rate of liver transplantation, pruritus or fatigue. Ursodiol and obeticholic acid are FDA-approved for the treatment of primary biliary cholangitis.
Primary sclerosing cholangitis[
UDCA use is associated with improved serum liver tests that do not always correlate with improved liver disease status. WHO Drug Information advises against its use in primary sclerosing cholangitis in unapproved doses beyond 13-15 mg/kg/day.
Intrahepatic cholestasis of pregnancy
UDCA has been used for intrahepatic cholestasis of pregnancy. UDCA lessens itching in the mother and may reduce the number of preterm births. Effects on fetal distress and other adverse outcomes are unlikely to be great.
Cholestasis
UDCA use is not licensed in children, as its safety and effectiveness have not been established. Evidence is accumulating that ursodeoxycholic acid is ineffective and unsafe in neonatal hepatitis and neonatal cholestasis.
Other conditions
UDCA has been suggested to be an adequate treatment of bile reflux gastritis.
In cystic fibrosis there is insufficient evidence to justify routine use of UDCA, especially as there is a lack of available data for long-term outcomes such as death or need for liver transplantation.
UDCA has also been used in non-alcoholic fatty liver disease, in liver bile duct-paucity syndromes such as biliary atresia, liver allograft rejection, and in Graft-versus-host disease involving the liver.
Ursodeoxycholic acid, the main component is 3a, 7β-dihydroxy-5β-cholestane-24-acid, is an organic compound, odorless and bitter. This product is soluble in ethanol, insoluble in chloroform; soluble in glacial acetic acid, dissolved in sodium hydroxide solution. Medically used to increase the secretion of bile acid, and to change the composition of bile, reduce cholesterol and cholesterol in bile, is conducive to gradual dissolution of cholesterol in gallstones.   

For the treatment of gallstones, cholestatic liver disease, fatty liver, various types of hepatitis, toxic liver disorders, cholecystitis, biliary and biliary dyspepsia, bile reflux gastritis, eye diseases.


 

Product Name Ursodeoxycholic Acid(UDCA)
Assay EP9;USP43;IP
Appearance White Powder
Shelf life 2 years
Brand HAOSAIL

 

 


QINGDAO HAOSAIL COA OF UDCA EP8
Pharmaceutical Grade Ursodeoxycholic Acid CAS No.: 128-13-2 with High Quality GMP Factory USP Ep Jp IP

QINGDAO HAOSAIL COA OF URSODEOXYCHOLIC ACID USP


Pharmaceutical Grade Ursodeoxycholic Acid CAS No.: 128-13-2 with High Quality GMP Factory USP Ep Jp IP


QINGDAO HAOSAIL  INVESTED CHOLIC ACID SERIES MANUFACTURER GMP CERTICIFICATION
Pharmaceutical Grade Ursodeoxycholic Acid CAS No.: 128-13-2 with High Quality GMP Factory USP Ep Jp IP

 

QINGDAO HAOSAIL R&D CENTE
Pharmaceutical Grade Ursodeoxycholic Acid CAS No.: 128-13-2 with High Quality GMP Factory USP Ep Jp IP
QINGDAO HAOSAIL PLANT
Pharmaceutical Grade Ursodeoxycholic Acid CAS No.: 128-13-2 with High Quality GMP Factory USP Ep Jp IP

QINGDAO HAOSAIL WORKSHOP
Pharmaceutical Grade Ursodeoxycholic Acid CAS No.: 128-13-2 with High Quality GMP Factory USP Ep Jp IP
QINGDAO HAOSAIL LAB

Pharmaceutical Grade Ursodeoxycholic Acid CAS No.: 128-13-2 with High Quality GMP Factory USP Ep Jp IP
QINGDAO HAOSAIL WAREHOUSE
Pharmaceutical Grade Ursodeoxycholic Acid CAS No.: 128-13-2 with High Quality GMP Factory USP Ep Jp IP


Qingdao Haosail Science Co., Ltd is a joint stock company, stock No. is 839542. We are manufacturer and globalsupplier of Spirulina,Chlorella, Spirulina blue(phycocyanin) and nutritional ingredients, and also a flexible and leading contract manufacturer of nutritional and dietary supplements, our products include powders, diversified tablets, hardgel capsules and softgel capsules, in bulk packaging and all kinds of retail packaging.

Also, based on our professional experience and capability of sourcing and purchasing diverse nutritional ingredients in China, we also provide our customers with a full range of raw materials which are used in Nutritional and Dietary industry. Our people are proficient in the knowledge and specialty of nutritional ingredients, so we are confident that we are able to offer the right and best ingredients to you. Moreover, benefit from our strategic partnership with many key manufacturers of nutritional ingredients, as well as our collective purchasing, we are able to offer very competitive price to you.

Our people is dedicated to supply nutritional and dietary products according to customers' requirements with consistently high quality and considerate service.

WELCOME To CONTACT US!

QINGDAO HAOSAIL COMPANY TEAM BUILDING


Pharmaceutical Grade Ursodeoxycholic Acid CAS No.: 128-13-2 with High Quality GMP Factory USP Ep Jp IP
QINGDAO HAOSAIL EXIHIBITION
Pharmaceutical Grade Ursodeoxycholic Acid CAS No.: 128-13-2 with High Quality GMP Factory USP Ep Jp IP

QINGDAO HAOSAIL PACKAGE
Pharmaceutical Grade Ursodeoxycholic Acid CAS No.: 128-13-2 with High Quality GMP Factory USP Ep Jp IP


 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier